✦ LIBER ✦

A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study

✍ Scribed by Sebag-Montefiore, D; Glynne-Jones, R; Falk, S; Meadows, H M; Maughan, T

Book ID: 109998641
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 113 KB
Volume: 93
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6602818

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of a triplet regimen in a

Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracil

✍ Guglielmi, A; Barni, S; Zaniboni, A; Pella, N; Belvedere, O; Beretta, G D; Gross 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 103 KB

Biweekly oxaliplatin, raltitrexed, 5-flu

Biweekly oxaliplatin, raltitrexed, 5-fluorouracil and folinic acid combination chemotherapy during preoperative radiation therapy for locally advanced rectal cancer: a phase I–II study

✍ Avallone, A; Delrio, P; Guida, C; Tatangelo, F; Petrillo, A; Marone, P; Cascini, 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 118 KB

A phase II study of irinotecan plus chro

A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients

✍ Garufi, C; Bria, E; Vanni, B; Zappalà, A M R; Sperduti, I; Terzoli, E 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 117 KB

A phase III trial of 5-fluorouracil and

A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. A mayo clinic/north central cancer treatment group study

✍ Michael J. O'Connell 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB 👁 2 views

The Mayo Clinic and the North Central Cancer Treatment Group (NCCTG) conducted a randomized clinical trial comparing five different combination chemotherapeutic regimens to single-agent 5-fluorouracil (5-FU), given by intravenous bolus technique (500 mg/m2 for 5 days) as a control, in the treatment

Phase I/II study of daily carboplatin, 5

Phase I/II study of daily carboplatin, 5-fluorouracil and concurrent radiation therapy for locally advanced non-small-cell lung cancer

✍ Yoshizawa, H; Tanaka, J; Kagamu, H; Maruyama, Y; Miyao, H; Ito, K; Sato, T; Iwas 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 95 KB

A phase I/II study of nedaplatin and 5-f

A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with T4 esophageal cancer: Japan Clinical Oncology Group trial (JCOG 9908)

✍ Satoshi Ishikura; Atsushi Ohtsu; Kuniaki Shirao; Kei Muro; Yoshikazu Kagami; Kei 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 296 KB